Immediate Impact
57 standout
Citing Papers
Advances in diagnosis and treatment of bladder cancer
2024 Standout
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
2024 Standout
Works of J. Frew being referenced
Phase III, Double-Blind, Randomized Trial That Compared Maintenance Lapatinib Versus Placebo After First-Line Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 1/2–Positive Metastatic Bladder Cancer
2017
A phase II/III, double-blind, randomized trial comparing maintenance lapatinib versus placebo after first line chemotherapy in HER1/2 positive metastatic bladder cancer patients.
2015
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| J. Frew | 166 | 77 | 187 | 128 | 30 | 444 | |
| C.H. Paine | 135 | 85 | 147 | 122 | 24 | 424 | |
| Eli Sapir | 154 | 99 | 91 | 78 | 30 | 451 | |
| Shuhei Sekii | 106 | 49 | 158 | 99 | 37 | 388 | |
| Felix Zwicker | 178 | 70 | 149 | 93 | 33 | 408 | |
| V. Svoboda | 186 | 159 | 124 | 144 | 33 | 481 | |
| A. Farella | 112 | 104 | 164 | 119 | 21 | 431 | |
| Tony Woo | 142 | 113 | 121 | 101 | 19 | 471 | |
| Franz‐Josef Prott | 141 | 99 | 87 | 103 | 22 | 457 | |
| Raffaele Solla | 118 | 131 | 94 | 158 | 24 | 466 | |
| Bin Qiu | 105 | 44 | 147 | 116 | 37 | 373 |
All Works
Loading papers...